MYSLEE Side Effects

7020556-2 | Delirium
on Sep 17, 2010 Female patient from JAPAN , 84 years of age, was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: delirium. Myslee dosage: . During the same period patient was treated with NITROPEN (View Nitropen Review and Nitropen Label ).

7020518-5 | Developmental Delay, Off Label Use
Patient was taking Myslee (View Usage). Patient had the following side effects: developmental delay, off label use on Sep 02, 2010 from JAPAN Additional patient health information: Male patient , 13 years of age, . Myslee dosage: .

6987807-1 | Delirium
Adverse event was reported on Sep 07, 2010 by a Female patient taking Myslee (View Usage) (Dosage: ) was diagnosed with insomnia and. Location: JAPAN , 71 years of age, After Myslee was administered, patient had the following side effects: delirium.

6984705-4 | Memory Impairment, Road Traffic Accident
on Sep 03, 2010 Male patient from JAPAN , 42 years of age, weighting 165.3 lb, was diagnosed with insomnia, depression (What is depression?) and was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: memory impairment, road traffic accident. Myslee dosage: . During the same period patient was treated with ABILIT (View Abilit Review and Abilit Label ), DEPROMEL (View Depromel Review and Depromel Label ), LUDIOMIL (View Ludiomil Review and Ludiomil Label ), LIMAS (View Limas Review and Limas Label ).


6968496-9 | Electrocardiogram Qt Prolonged
on Aug 19, 2010 Female patient from JAPAN , 94 years of age, was treated with Myslee (View Usage). Patient had the following side effects: electrocardiogram qt prolonged. Myslee dosage: .

6968466-0 | Liver Disorder
Patient was taking Myslee (View Usage). After Myslee was administered, patient had the following side effects: liver disorder on Aug 26, 2010 from JAPAN Additional patient health information: Female patient , 58 years of age, . Myslee dosage: .

6968382-4 | Coma Scale Abnormal, Hypotension, Renal Failure Acute, Renal Tubular Necrosis, Rhabdomyolysis
Adverse event was reported on Aug 26, 2010 by a Female patient taking Myslee (View Usage) (Dosage: ) was diagnosed with suicide attempt and. Location: JAPAN , 35 years of age, Patient experienced the following unwanted or unexpected effects: coma scale abnormal, hypotension, renal failure acute, renal tubular necrosis, rhabdomyolysis. During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized.

6927509-0 | Neonatal Asphyxia
on Aug 06, 2010 Male patient from JAPAN , weighting 5.67 lb, was treated with Myslee (View Usage). Patient had the following side effects: neonatal asphyxia. Myslee dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ), SEDIEL (View Sediel Review and Sediel Label ), DEPAS (View Depas Review and Depas Label ), HALCION (View Halcion Review and Halcion Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), PZC (View Pzc Review and Pzc Label ).

6915933-1 | Delirium
on Jul 30, 2010 Female patient from JAPAN , 65 years of age, was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: delirium. Myslee dosage: .

6907944-7 |
Patient was taking Myslee (View Usage). on Jul 26, 2010 from JAPAN Additional patient health information: Male patient , weighting 141.5 lb, . Myslee dosage: . During the same period patient was treated with SENIRAN (View Seniran Review and Seniran Label ), DEPAS (View Depas Review and Depas Label ), PAXIL (View Paxil Review and Paxil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6899934-8 | Platelet Count Decreased, Reversible Posterior Leukoencephalopathy Syndrome
Adverse event was reported on Jul 22, 2010 by a Male patient taking Myslee (View Usage) (Dosage: Unit Dose: 10 Mg) was diagnosed with insomnia and. Location: JAPAN , 60 years of age, weighting 141.1 lb, Patient had the following side effects: platelet count decreased, reversible posterior leukoencephalopathy syndrome. During the same period patient was treated with SUNITINIB MALATE (Unit Dose: 50 Mg) (View Sunitinib Malate Review and Sunitinib Malate Label ), GLEEVEC (View Gleevec Review and Gleevec Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), ALLELOCK (View Allelock Review and Allelock Label ). Patient was hospitalized.

6899910-5 | Fall, Fracture
on Jul 23, 2010 Female patient from JAPAN , 80 years of age, was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: fall (What is fall?), fracture (What is fracture?). Myslee dosage: .

6899908-7 | Altered State Of Consciousness, Amnesia, Confusional State, Delirium, Dizziness, Fall, Head Discomfort, Restlessness, Somnolence
on Jul 27, 2010 Female patient from JAPAN , 85 years of age, weighting 125.7 lb, was diagnosed with insomnia, type 2 diabetes mellitus and was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, amnesia, confusional state, delirium, dizziness (What is dizziness?), fall (What is fall?), head discomfort, restlessness, somnolence. Myslee dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), KETOPROFEN (Tape) (View Ketoprofen Review and Ketoprofen Label ).

6886989-X | Altered State Of Consciousness, Amnesia, Confusional State, Delirium, Dizziness, Fall, Head Discomfort, Restlessness, Somnolence
Patient was taking Myslee (View Usage). Patient had the following side effects: altered state of consciousness, amnesia, confusional state, delirium, dizziness (What is dizziness?), fall (What is fall?), head discomfort, restlessness, somnolence on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, weighting 125.7 lb, was diagnosed with insomnia and. Myslee dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), KETOPROFEN (Tape) (View Ketoprofen Review and Ketoprofen Label ).

6882076-5 | Respiratory Dyskinesia, Tardive Dyskinesia
Adverse event was reported on Jul 20, 2010 by a Male patient taking Myslee (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, After Myslee was administered, patient had the following side effects: respiratory dyskinesia, tardive dyskinesia. During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6879846-6 | Coma Scale Abnormal, Hypotension, Renal Failure Acute, Rhabdomyolysis
on Jul 16, 2010 Female patient from JAPAN , 35 years of age, was diagnosed with suicide attempt and was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: coma scale abnormal, hypotension, renal failure acute, rhabdomyolysis. Myslee dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ). Patient was hospitalized.

6862253-X | Fall, Fracture
on Jul 12, 2010 Female patient from JAPAN , 80 years of age, was treated with Myslee (View Usage). Patient had the following side effects: fall (What is fall?), fracture (What is fracture?). Myslee dosage: .

6855987-4 | Respiratory Dyskinesia, Tardive Dyskinesia
Patient was taking Myslee (View Usage). After Myslee was administered, patient had the following side effects: respiratory dyskinesia, tardive dyskinesia on Jul 07, 2010 from JAPAN Additional patient health information: Male patient , 73 years of age, . Myslee dosage: . During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6855968-0 | Blood Glucose Increased, Sleep-related Eating Disorder, Somnambulism
Adverse event was reported on Jul 07, 2010 by a Female patient taking Myslee (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, sleep-related eating disorder, somnambulism. Patient was hospitalized.

6831147-8 | Delirium
on Jul 01, 2010 Female patient from JAPAN , 65 years of age, was treated with Myslee (View Usage). Patient had the following side effects: delirium. Myslee dosage: .

6802842-1 | Neonatal Asphyxia
on Jun 16, 2010 Male patient from JAPAN , weighting 5.67 lb, was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: neonatal asphyxia. Myslee dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ), SEDIEL (View Sediel Review and Sediel Label ), DEPAS (View Depas Review and Depas Label ), HALCION (View Halcion Review and Halcion Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), PZC (View Pzc Review and Pzc Label ).

6795207-2 | Cellulitis, Induration, Pain In Extremity, Thrombophlebitis
Patient was taking Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), induration, pain in extremity, thrombophlebitis on Jun 17, 2010 from JAPAN Additional patient health information: Female patient , 79 years of age, was diagnosed with insomnia, endoscopy (What is endoscopy?), hyperlipidaemia, hypertension, constipation (What is constipation?) and. Myslee dosage: . During the same period patient was treated with HORIZON (View Horizon Review and Horizon Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), ALOSENN (View Alosenn Review and Alosenn Label ), DEPAS (View Depas Review and Depas Label ).

6784333-X | Blood Creatine Phosphokinase Increased, Dehydration, Rhabdomyolysis, Transaminases Increased
Adverse event was reported on Jun 10, 2010 by a Male patient taking Myslee (View Usage) (Dosage: ) . Location: JAPAN , 70 years of age, Patient had the following side effects: blood creatine phosphokinase increased, dehydration, rhabdomyolysis, transaminases increased. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ).

6771318-2 | Cellulitis, Induration, Pain In Extremity, Thrombophlebitis
on Jun 04, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with insomnia, endoscopy (What is endoscopy?), hyperlipidaemia, hypertension and was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: cellulitis (What is cellulitis?), induration, pain in extremity, thrombophlebitis. Myslee dosage: . During the same period patient was treated with HORIZON (View Horizon Review and Horizon Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), ALOSENN (View Alosenn Review and Alosenn Label ), DEPAS (View Depas Review and Depas Label ).

6770582-3 | Amnesia, Road Traffic Accident, Somnambulism
on Jun 03, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, road traffic accident, somnambulism. Myslee dosage: . During the same period patient was treated with ANTIDEPRESSANTS (NOS) (View Antidepressants (nos) Review and Antidepressants (nos) Label ).

6751017-3 | Neonatal Asphyxia
Patient was taking Myslee (View Usage). Patient had the following side effects: neonatal asphyxia on May 21, 2010 from JAPAN Additional patient health information: Male patient , weighting 5.67 lb, . Myslee dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ), SEDIEL (View Sediel Review and Sediel Label ), DEPAS (View Depas Review and Depas Label ), HALCION (View Halcion Review and Halcion Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), PZC (View Pzc Review and Pzc Label ).

6749045-7 | Blood Creatine Phosphokinase Increased, Neuroleptic Malignant Syndrome, Rhabdomyolysis, Transaminases Increased
Adverse event was reported on May 20, 2010 by a Male patient taking Myslee (View Usage) (Dosage: ) . Location: JAPAN , 70 years of age, After Myslee was administered, patient had the following side effects: blood creatine phosphokinase increased, neuroleptic malignant syndrome, rhabdomyolysis, transaminases increased. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ).

6749007-X | Cellulitis, Induration, Pain In Extremity, Thrombophlebitis
on May 20, 2010 Female patient from JAPAN , 79 years of age, was diagnosed with insomnia, endoscopy (What is endoscopy?), hyperlipidaemia, hypertension and was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), induration, pain in extremity, thrombophlebitis. Myslee dosage: . During the same period patient was treated with HORIZON (View Horizon Review and Horizon Label ), GLUCAGON (View Glucagon Review and Glucagon Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), BUFFERIN (View Bufferin Review and Bufferin Label ), ALOSENN (View Alosenn Review and Alosenn Label ), DEPAS (View Depas Review and Depas Label ).

6735641-X | Drowning
on May 12, 2010 Female patient from JAPAN , 66 years of age, was treated with Myslee (View Usage). Patient had the following side effects: drowning (What is drowning?). Myslee dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ).

6715363-1 | Luteal Phase Deficiency
Patient was taking Myslee (View Usage). After Myslee was administered, patient had the following side effects: luteal phase deficiency on Apr 27, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, . Myslee dosage: . During the same period patient was treated with CONSTAN (View Constan Review and Constan Label ).

6688242-6 | Myoclonus, Speech Disorder, Tremor
Adverse event was reported on Mar 18, 2010 by a Male patient taking Myslee (View Usage) (Dosage: ) was diagnosed with insomnia, gastric cancer and. Location: JAPAN , 81 years of age, weighting 106.9 lb, Patient experienced the following unwanted or unexpected effects: myoclonus, speech disorder, tremor. During the same period patient was treated with FOIPAN (View Foipan Review and Foipan Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), RHYTHMY (View Rhythmy Review and Rhythmy Label ), OMEPRAL (View Omepral Review and Omepral Label ), DETRUSITOL (View Detrusitol Review and Detrusitol Label ), STRONG NEO MINOPHAGEN C (View Strong Neo-minophagen C Review and Strong Neo-minophagen C Label ).

6674772-X | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Mar 26, 2010 Male patient from JAPAN , 74 years of age, was treated with Myslee (View Usage). Patient had the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Myslee dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), DASEN (View Dasen Review and Dasen Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), EURODIN (View Eurodin Review and Eurodin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6674760-3 | Completed Suicide
on Apr 01, 2010 Male patient from JAPAN , 24 years of age, was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: completed suicide. Myslee dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ).

6669313-7 | Neuroleptic Malignant Syndrome
Patient was taking Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome on Mar 25, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, . Myslee dosage: .

6665681-0 | Hepatic Function Abnormal
Adverse event was reported on Mar 23, 2010 by a Male patient taking Myslee (View Usage) (Dosage: ) . Location: JAPAN , 50 years of age, Patient had the following side effects: hepatic function abnormal. During the same period patient was treated with MEILAX (View Meilax Review and Meilax Label ), HARNAL (View Harnal Review and Harnal Label ), VFEND (View Vfend Review and Vfend Label ), GASCON (View Gascon Review and Gascon Label ), AMOBAN (View Amoban Review and Amoban Label ), SP TROCHE (View Sp Troche Review and Sp Troche Label ), DEPAS (View Depas Review and Depas Label ), SENNOSIDE A+B (View Sennoside A+b Review and Sennoside A+b Label ). Patient was hospitalized.

6657959-1 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Mar 18, 2010 Male patient from JAPAN , 74 years of age, was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Myslee dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), DASEN (View Dasen Review and Dasen Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), EURODIN (View Eurodin Review and Eurodin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6655259-7 | Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion
on Mar 17, 2010 Male patient from JAPAN , 74 years of age, was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, inappropriate antidiuretic hormone secretion. Myslee dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), DASEN (View Dasen Review and Dasen Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), EURODIN (View Eurodin Review and Eurodin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6557573-2 | Delirium
Patient was taking Myslee (View Usage). Patient had the following side effects: delirium on Jan 21, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with cancer pain and. Myslee dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), REPLAS 3 (View Replas 3 Review and Replas 3 Label ).

6537426-6 | Epilepsy, Musculoskeletal Stiffness, Unresponsive To Stimuli
Adverse event was reported on Jan 05, 2010 by a Female patient taking Myslee (View Usage) (Dosage: ) was diagnosed with insomnia, depression (What is depression?) and. Location: JAPAN , 54 years of age, After Myslee was administered, patient had the following side effects: epilepsy (What is epilepsy?), musculoskeletal stiffness, unresponsive to stimuli. During the same period patient was treated with ANEXATE (^injected Over 10 Seconds.^) (View Anexate Review and Anexate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ABILIT (View Abilit Review and Abilit Label ), SOLANAX (View Solanax Review and Solanax Label ), DEPAS (View Depas Review and Depas Label ), ROHIPNOL (View Rohipnol Review and Rohipnol Label ).

6524057-7 | Delirium
on Dec 21, 2009 Male patient from JAPAN , 80 years of age, was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: delirium. Myslee dosage: .

6524050-4 | Hyperkalaemia
on Dec 21, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with hypertension and was treated with Myslee (View Usage). Patient had the following side effects: hyperkalaemia. Myslee dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ). Patient was hospitalized.

6524030-9 | Altered State Of Consciousness, Renal Failure Acute, Rhabdomyolysis
Patient was taking Myslee (View Usage). After Myslee was administered, patient had the following side effects: altered state of consciousness, renal failure acute, rhabdomyolysis on Dec 21, 2009 from JAPAN Additional patient health information: Female patient , 53 years of age, weighting 172.0 lb, was diagnosed with insomnia, anxiety (What is anxiety?) and. Myslee dosage: Large Doses Routinely.. During the same period patient was treated with MEILAX (Large Doses Routinely.) (View Meilax Review and Meilax Label ), CERCINE (Large Doses Routinely.) (View Cercine Review and Cercine Label ). Patient was hospitalized.

6524029-2 | Anxiety, Delirium, Irritability, Restlessness, Sleep Disorder
Adverse event was reported on Dec 18, 2009 by a Female patient taking Myslee (View Usage) (Dosage: ) was diagnosed with gastric ulcer, anxiety (What is anxiety?), pain (What is pain?) and. Location: JAPAN , 71 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), delirium, irritability, restlessness, sleep disorder (What is sleep disorder?). During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), DEPAS (View Depas Review and Depas Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ). Patient was hospitalized.

6492855-4 | Hyperkalaemia, Overdose
on Nov 25, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with hypertension and was treated with Myslee (View Usage). Patient had the following side effects: hyperkalaemia, overdose. Myslee dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ). Patient was hospitalized.

6479678-7 | Hyperkalaemia, Overdose
on Nov 25, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with hypertension and was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: hyperkalaemia, overdose. Myslee dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ). Patient was hospitalized.

6479647-7 | Aggression, Amnesia, Self Injurious Behaviour, Somnambulism
Patient was taking Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, amnesia, self injurious behaviour, somnambulism on Nov 26, 2009 from JAPAN Additional patient health information: Male patient , 53 years of age, was diagnosed with panic disorder (What is panic disorder?), insomnia and. Myslee dosage: . During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), LIMAS (View Limas Review and Limas Label ).

6462097-7 | Anxiety, Delirium, Irritability, Restlessness, Sleep Disorder
Adverse event was reported on Nov 18, 2009 by a Female patient taking Myslee (View Usage) (Dosage: ) was diagnosed with gastric ulcer, anxiety (What is anxiety?), pain (What is pain?) and. Location: JAPAN , 71 years of age, weighting 110.2 lb, Patient had the following side effects: anxiety (What is anxiety?), delirium, irritability, restlessness, sleep disorder (What is sleep disorder?). During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), DEPAS (View Depas Review and Depas Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ). Patient was hospitalized.

6398797-7 | Amnesia, Cognitive Disorder, Road Traffic Accident
on Oct 02, 2009 Female patient from JAPAN , weighting 88.18 lb, was diagnosed with insomnia, reflux oesophagitis, anxiety disorder, constipation (What is constipation?) and was treated with Myslee (View Usage). After Myslee was administered, patient had the following side effects: amnesia, cognitive disorder, road traffic accident. Myslee dosage: . During the same period patient was treated with RHYTHMY (Unk) (View Rhythmy Review and Rhythmy Label ), OMEPRAL (Unk) (View Omepral Review and Omepral Label ), MEILAX (Unk) (View Meilax Review and Meilax Label ), BIOFERMIN (Unk) (View Biofermin Review and Biofermin Label ), MAG LAX (Unk) (View Mag-lax Review and Mag-lax Label ).

6390645-4 | Pleurisy
on Sep 28, 2009 Female patient from JAPAN , 78 years of age, was treated with Myslee (View Usage). Patient experienced the following unwanted or unexpected effects: pleurisy. Myslee dosage: . Patient was hospitalized.

6356740-0 | Amnesia, Cognitive Disorder, Road Traffic Accident
Patient was taking Myslee (View Usage). Patient had the following side effects: amnesia, cognitive disorder, road traffic accident on Sep 04, 2009 from JAPAN Additional patient health information: Female patient , 78 years of age, . Myslee dosage: .